These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 25910879)

  • 1. Investigation of Saliva as an Alternative to Plasma Monitoring of Voriconazole.
    Vanstraelen K; Maertens J; Augustijns P; Lagrou K; de Loor H; Mols R; Annaert P; Malfroot A; Spriet I
    Clin Pharmacokinet; 2015 Nov; 54(11):1151-60. PubMed ID: 25910879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of plasma unbound fraction of voriconazole in patients treated with a prophylactic or a curative treatment.
    Florent A; Gandia P; Seraissol P; Chatelut E; Houin G
    Ther Drug Monit; 2014 Dec; 36(6):752-8. PubMed ID: 24819971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of hypoalbuminemia on voriconazole pharmacokinetics in critically ill adult patients.
    Vanstraelen K; Wauters J; Vercammen I; de Loor H; Maertens J; Lagrou K; Annaert P; Spriet I
    Antimicrob Agents Chemother; 2014 Nov; 58(11):6782-9. PubMed ID: 25182655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic drug monitoring of voriconazole helps to decrease the percentage of patients with off-target trough serum levels.
    Guinea J; Escribano P; Marcos-Zambrano LJ; Peláez T; Kestler M; Muñoz P; Vena A; López-Fabal F; Bouza E
    Med Mycol; 2016 May; 54(4):353-60. PubMed ID: 26739190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Voriconazole dosing and therapeutic drug monitoring in children: experience from a paediatric tertiary care centre.
    Boast A; Curtis N; Cranswick N; Gwee A
    J Antimicrob Chemother; 2016 Jul; 71(7):2031-6. PubMed ID: 27009030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of total and free voriconazole in human plasma: Application to pharmacokinetic study and therapeutic monitoring.
    Resztak M; Kosicka K; Zalewska P; Krawiec J; Główka FK
    J Pharm Biomed Anal; 2020 Jan; 178():112952. PubMed ID: 31708268
    [No Abstract]   [Full Text] [Related]  

  • 7. Dosing and therapeutic drug monitoring of voriconazole in bottlenose dolphins (Tursiops truncatus).
    Ferrier K; van Elk CE; Bunskoek PE; van den Broek M
    Med Mycol; 2017 Feb; 55(2):155-163. PubMed ID: 27703023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic Drug Monitoring of Voriconazole in Children from a Tertiary Care Center in China.
    Hu L; Dai TT; Zou L; Li TM; Ding XS; Yin T
    Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30150475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of different pharmacokinetic models to describe and predict pharmacokinetics of voriconazole in magellanic penguins following oral administration.
    Parsley RA; Mutlow AG; Hansted J; Taverne FJ; Tell LA; Gehring R
    J Vet Pharmacol Ther; 2019 Jan; 42(1):74-84. PubMed ID: 30175535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring trough voriconazole plasma concentrations in haematological patients: real life multicentre experience.
    Racil Z; Winterova J; Kouba M; Zak P; Malaskova L; Buresova L; Toskova M; Lengerova M; Kocmanova I; Weinbergerova B; Timilsina S; Rolencova M; Cetkovsky P; Mayer J
    Mycoses; 2012 Nov; 55(6):483-92. PubMed ID: 22429709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Voriconazole and posaconazole therapeutic drug monitoring: a retrospective study.
    Yi WM; Schoeppler KE; Jaeger J; Mueller SW; MacLaren R; Fish DN; Kiser TH
    Ann Clin Microbiol Antimicrob; 2017 Sep; 16(1):60. PubMed ID: 28893246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic drug monitoring and safety of intravenous voriconazole formulated with sulfobutylether β-cyclodextrin in haematological patients with renal impairment.
    Kim SH; Kwon JC; Park C; Han S; Yim DS; Choi JK; Cho SY; Lee HJ; Park SH; Choi SM; Choi JH; Yoo JH; Lee DG; Lee JW
    Mycoses; 2016 Oct; 59(10):644-51. PubMed ID: 27324913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pharmacokinetic comparison of two voriconazole formulations and the effect of CYP2C19 polymorphism on their pharmacokinetic profiles.
    Chung H; Lee H; Han HK; An H; Lim KS; Lee YJ; Cho JY; Yoon SH; Jang IJ; Yu KS
    Drug Des Devel Ther; 2015; 9():2609-16. PubMed ID: 25999694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative Evaluation of the Predictive Performances of Three Different Structural Population Pharmacokinetic Models To Predict Future Voriconazole Concentrations.
    Farkas A; Daroczi G; Villasurda P; Dolton M; Nakagaki M; Roberts JA
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6806-6812. PubMed ID: 27600031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Voriconazole therapeutic drug monitoring in critically ill patients improves efficacy and safety of antifungal therapy.
    Li H; Li M; Yan J; Gao L; Zhou L; Wang Y; Li Q; Wang J; Chen T; Wang T; Zheng J; Qiang W; Zhang Y; Shi Q
    Basic Clin Pharmacol Toxicol; 2020 Dec; 127(6):495-504. PubMed ID: 32639669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Key Elements in Determining Voriconazole Protein Binding Characteristics: Comment on "Determination of Plasma Unbound Fraction of Voriconazole in Patients Treated With a Prophylactic or a Curative Treatment".
    Vanstraelen K; Pauwels S; Oyaert M; Maertens J; Spriet I
    Ther Drug Monit; 2015 Aug; 37(4):551-3. PubMed ID: 25525765
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of proton pump inhibitor on plasma voriconazole concentration in Thai patients.
    Chayakulkeeree M; Poovipirom N; Siengwattana P; Maneerattanaporn M
    J Med Assoc Thai; 2015 Mar; 98(3):232-7. PubMed ID: 25920292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Therapeutic Drug Monitoring and Cytochrome P450 2C19 Genotyping on Clinical Outcomes of Voriconazole: A Systematic Review.
    Lee J; Ng P; Hamandi B; Husain S; Lefebvre MJ; Battistella M
    Ann Pharmacother; 2021 Apr; 55(4):509-529. PubMed ID: 32772568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimization of Voriconazole Therapy for the Treatment of Invasive Fungal Infections in Adults.
    Mangal N; Hamadeh IS; Arwood MJ; Cavallari LH; Samant TS; Klinker KP; Bulitta J; Schmidt S
    Clin Pharmacol Ther; 2018 Nov; 104(5):957-965. PubMed ID: 29315506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral administration and younger age decrease plasma concentrations of voriconazole in pediatric patients.
    Kato K; Nagao M; Yamamoto M; Matsumura Y; Takakura S; Fukuda K; Ichiyama S
    J Infect Chemother; 2016 Jan; 22(1):27-31. PubMed ID: 26538245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.